Diana L. Donnelly‐Roberts
AbbVie (United States)(US)AbbVie (Japan)
Publications by Year
Research Areas
Nicotinic Acetylcholine Receptors Study, Receptor Mechanisms and Signaling, Cholinesterase and Neurodegenerative Diseases, Adenosine and Purinergic Signaling, Ion channel regulation and function
Most-Cited Works
- → A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat(2006)403 cited
- → Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine Receptors(1998)368 cited
- → Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors(2009)271 cited
- → Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states(2007)262 cited
- → Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors(1996)231 cited
- → Structure−Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7Antagonists(2006)227 cited